Showing results (201-210 of 255) with videos related to
Sort By:
Pageof 26
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 3, 2017
Comparison of Control of Clostridium difficile Infection in Six English Hospitals Using Whole-Genome SequencingDavid W Eyre, Warren N Fawley, Anu Rajgopal, et al.Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|July 1, 2022
A point-prevalence study on community and inpatient Clostridioides difficile infections (CDI): results from Combatting Bacterial Resistance in Europe CDI (COMBACTE-CDI), July to November 2018Virginie F Viprey, Georgina L Davis, Anthony D Benson, et al.Jac-Antimicrobial Resistance|July 24, 2024
Antimicrobial susceptibility in Clostridioides difficile varies according to European region and isolate sourceJane Freeman, Virginie Viprey, Duncan Ewin, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 17, 2018
Patient and Strain Characteristics Associated With Clostridium difficile Transmission and Adverse OutcomesJessica S H Martin, David W Eyre, Warren N Fawley, et al.The Lancet. Infectious Diseases|January 29, 2017
Effects of control interventions on Clostridium difficile infection in England: an observational studyKate E Dingle, Xavier Didelot, T Phuong Quan, et al.Clinical and Vaccine Immunology : CVI|July 17, 2015
Profiling Humoral Immune Responses to Clostridium difficile-Specific Antigens by Protein Microarray AnalysisOla H Negm, Mohamed R Hamed, Elizabeth M Dilnot, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 28, 2017
A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of Intravenous Iclaprim Vs Vancomycin for the Treatment of Acute Bacterial Skin and Skin Structure Infections Suspected or Confirmed to be Due to Gram-Positive Pathogens: REVIVE-1David B Huang, William O'Riordan, J Scott Overcash, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 17, 2018
Two Distinct Patterns of Clostridium difficile Diversity Across Europe Indicating Contrasting Routes of SpreadDavid W Eyre, Kerrie A Davies, Georgina Davis, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 4, 2017
Contribution to Clostridium Difficile Transmission of Symptomatic Patients With Toxigenic Strains Who Are Fecal Toxin NegativeDamian P C Mawer, David W Eyre, David Griffiths, et al.The Lancet. Infectious Diseases|May 3, 2017
Efficacy and safety of ridinilazole compared with vancomycin for the treatment of Clostridium difficile infection: a phase 2, randomised, double-blind, active-controlled, non-inferiority studyRichard J Vickers, Glenn S Tillotson, Richard Nathan, et al.Pageof 26